Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales
13th May 2022 Uncategorised 0 Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales
aliu
Fri, 05/13/2022 – 15:58
More: Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales
Source: fierce